Efficacy of the ECHOMANTRA Individual Online Intervention to Support Recovery From Eating Disorders in Adolescent Patients: A Randomized Controlled Trial
Abstract
INTRODUCTION
ECHOMANTRA supports both patients and carers as an adjunct to treatment in Eating Disorders (Eds).
OBJECTIVE
This study evaluates the efficacy, acceptability, and feasibility of ECHOMANTRA as an add-on to treatment-as-usual (TAU) for adolescent ED patients and their carers, using an individualised online format.
METHOD
A multicenter, randomized controlled trial compared two parallel groups (TAU + ECHOMANTRA vs. TAU alone) with 108 patient-carer dyads.
RESULTS
Patients in both groups showed improvements in BMI, ED symptoms, emotional state, quality of life, confidence in change, obsessiveness, and perfectionism, with larger effects in the ECHOMANTRA + TAU group. Carers in both groups improved in expressed emotion, accommodation, perceived ED impact, and emotional well-being, with greater effects in the ECHOMANTRA + TAU group. Only carers in this group improved in caregiver skills. Completion rates were high (patients: 87.04%, carers: 81.84%), with strong satisfaction.
CONCLUSIONS
ECHOMANTRA is an effective, feasible online intervention that enhances outcomes for adolescent ED patients and carers when added to standard care.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.